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Abstract
Background:  Hepatoma-derived growth factor (HDGF) belongs to a polypeptide family
containing five additional members called HDGF related proteins 1–4 (HRP-1 to -4) and Lens
epithelial derived growth factor. Whereas some family members such as HDGF and HRP-2 are
expressed in a wide range of tissues, the expression of others is very restricted. HRP-1 and -4 are
only expressed in testis, HRP-3 only in the nervous system. Here we investigated the expression
of HDGF, HRP-2 and HRP-3 in the central nervous system of adult mice on the cellular level by
immunohistochemistry. In addition we performed Western blot analysis of various brain regions as
well as neuronal and glial cell cultures.
Results: HDGF was rather evenly expressed throughout all brain regions tested with the lowest
expression in the substantia nigra. HRP-2 was strongly expressed in the thalamus, prefrontal and
parietal cortex, neurohypophysis, and the cerebellum, HRP-3 in the bulbus olfactorius, piriform
cortex and amygdala complex. HDGF and HRP-2 were found to be expressed by neurons,
astrocytes and oligodendrocytes. In contrast, strong expression of HRP-3 in the adult nervous
system is restricted to neurons, except for very weak expression in oligodendrocytes in the brain
stem. Although the majority of neurons are HRP-3 positive, some like cerebellar granule cells are
negative.
Conclusion:  The coexpression of HDGF and HRP-2 in glia and neurons as well as the
coexpression of all three proteins in many neurons suggests different functions of members of the
HDGF protein family in cells of the central nervous system that might include proliferation as well
as cell survival. In addition the restricted expression of HRP-3 point to a special function of this
family member for neuronal cells.
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Background
The family of Hepatoma derived growth factor (HDGF)
and HDGF related proteins (HRPs) comprises six mem-
bers which belong to different subgroups according to
their length and isoelectric points. [1]. Little is known
about the function of the different family members. So
far, most studies addressed HDGF which was initially
purified from the supernatant of human hepatoma cell
lines [2,3].
Five HDGF homologous proteins have been identified so
far [1,4,5]. Four of these proteins have been termed HRP-
1 to -4 (HDGF Related Proteins 1 to 4), the fifth p52/75
or LEDGF (Lens Epithelium-derived growth factor).
HDGF and its homologues display between 54% and
78% sequence identity among the 91 N-terminal amino
acids. Because of this similarity the amino-terminal region
has been termed Homologue to Amino Terminus of HDGF
(HATH region [4]). In contrast, the length and amino acid
sequence of HRP's C-terminal regions vary suggesting a
modular structure of these proteins. This is supported by
structural data obtained by NMR [6]. The main cellular
localization of HDGF is nuclear, although in some cells
HDGF can be found in the cytosol [3,7,8]. HDGF has two
nuclear localization signals, one in the conserved HATH
region, the other one in the C-terminal area specific for
the different family members. The nuclear localization
has been shown to be a prerequisite for the mitogenic
activity of intracellular HDGF [9,10] whereas extracellular
HDGF seems to signal through signal transduction path-
ways from the cell surface [11,12]. Except for their growth
factor activity functions of HDGF family members are
largely unknown. HRP-1 is believed to play a role in sper-
matogenesis [13] and LEDGF has been shown to function
as a transcriptional activator. It also binds to and potenti-
ates the activity of HIV integrase [14-17]. The latter activity
has also been shown for HRP-2 [18]. For HDGF it has
been speculated that it plays a role in renal, liver, lung and
heart development [7,19-22]. In addition, a growing
number of studies report a possible role of this growth fac-
tor in the development of different types of cancers [23-
26]. In contrast, no functional data exist for HRP-3. The
expression of this protein in contrast to the other family
members is mainly restricted to nervous tissue [5,27].
Here we examine the cellular expression of HDGF, HRP-2
and HRP-3 in the adult rodent brain by Western blot anal-
ysis and immunhistochemistry. Data from these studies
are compared to the expression of all three proteins in pri-
mary and secondary cell cultures of neurons, astrocytes,
microglia and oligodendrocytes.
Results
Western blot analysis of various brain regions
Of the six members of the Hepatoma-derived growth fac-
tor family only HDGF, HRP-2 and HRP-3 are expressed in
the central nervous system.
To study the expression of these factors in more detail we
performed Western blot analysis of samples obtained
from different brain regions using HDGF, HRP-2, and
HRP-3 specific antibodies. HDGF was rather evenly
expressed throughout all brain regions investigated (Fig.
1), except for low levels in the substantia nigra. The
HDGF-antiserum detected two polypeptides of 38 kDa
and 40 kDa, the smaller form being predominant in all
brain regions. In contrast to HDGF, expression of HRP-2
and HRP-3 varied substantially between different brain
regions (Fig. 1). HRP-2 was strongly expressed in the tha-
lamus, prefrontal and parietal cortex, neurohypophysis,
and the cerebellum. In some tissues, the HRP-2 antiserum
recognized up to three proteins of 90, 110 and 125 kDa.
HRP-3 expression was high in the bulbus olfactorius, pir-
iform cortex and amygdala complex. The HRP-3 antise-
rum recognized a single polypeptide of 30 kDa, only in
the amygdala complex an additional faint 35 kDa
Expression of HDGF family members in different brain  regions Figure 1
Expression of HDGF family members in different 
brain regions. Tissue homogenates of different rat brain 
regions were prepared as described under material and 
methods and subjected to Western blot analysis with anti-
bodies against the proteins listed. Brain regions examined 
were as indicated above the figure. The Coomassie stained 
PVDF membrane is shown underneath the figure to demon-
strate equal loading for the different brain regions. Molecular 
weights of marker proteins in kiloDalton are given on the 
right side of the figure.BMC Neuroscience 2006, 7:6 http://www.biomedcentral.com/1471-2202/7/6
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polypeptide was detectable. As for HDGF, substantia nigra
contained only low amounts of HRP-2 and HRP-3 (Fig.
1).
Immunohistochemical analysis of neuronal expression in 
brains of adult mice
For a more detailed expression analysis we performed
immunhistochemistry to detect HDGF, HRP-2 and HRP-
3 in brain section of adult mice and compared their
expression to that of cell type specific markers. Figure 2
shows cerebellar sections immunostained for HDGF (Fig.
2A), HRP-2 (Fig. 2D) and HRP-3 (Fig. 2G), respectively.
These sections reveal that HDGF and HRP-2 are found in
the internal granule cell layer (IGL), Purkinje cell layer
(PCL) and to a lower extent in the molecular cell layer
(MCL). Simultaneous immunostaining for HDGF or
HRP-2 and NeuN – a marker for granule cells in the cere-
bellum [28] -, respectively, yielded comparable patterns of
expression and confirmed that HDGF as well as HRP-2 are
expressed in granule cells of the IGL (Fig. 2C+F). In con-
trast, HRP-3 did not colocalize with NeuN and is therefore
not expressed by granule cells (Fig. 2I). Nevertheless a few
HRP-3 positive cells were detected in the IGL (Fig. 2I
arrowheads). These cells most likely represent Golgi cells.
To a lower extent also cells of the MCL are stained most
likely representing basket/stellate cells, another type of
inhibitory interneuron in the cerebellum (Fig. 2G).
The overlay figures reveal that HDGF and HRP-2 expres-
sion is not restricted to granule cells. Cells in the adjacent
PCL also strongly express HDGF and HRP-2 (Fig. 2C+F) as
well as HRP-3 (Fig. 2I).
To confirm the expression of HDGF, HRP-2 and HRP-3 in
Purkinje cells double staining with calbindin a marker for
these cells in murine cerebellum [29] was performed.
Expression of all three family members was detected in
the nuclei of Purkinje cells (arrowheads in Fig. 3A, D, G)
Expression of HDGF family members in granular cells of the  cerebellum Figure 2
Expression of HDGF family members in granular 
cells of the cerebellum. Antibodies against HDGF (A), 
HRP-2 (D), HRP-3 (G) and NeuN (B, E, H) were used to 
detect the proteins in brain slices of adult mice. Double stain-
ings demonstrate that in contrast to HDGF and HRP-2, HRP-
3 is not expressed in NeuN positive granular cells of the cer-
ebellum. Distinct cells in the IGL detected by HRP-3 antibod-
ies are most likely Golgi cells (I, arrowheads). In addition 
HRP-3 is also clearly expressed in the PCL and weakly in 
some cells of the MCL (I). MCL: molecular cell layer; PCL: 
purkinje cell layer; IGL: internal granular cell layer; WM: 
white matter. Bars are 80 µm.
Expression of HDGF family members in Purkinje cells Figure 3
Expression of HDGF family members in Purkinje 
cells. Antibodies against HDGF (A), HRP-2 (D), HRP-3 (G) 
and Calbindin (B, E, H) were used to detect the respective 
proteins in brain slices of adult mice. Double stainings dem-
onstrate that all three members are expressed in nuclei of 
Calbindin positive cells of the cerebellum (arrowheads in A, 
D and G). Arrows in C and F indicate HDGF and HRP-2 pos-
itive cells in the white matter. Arrows in I point to HRP-3 
expressing cells in the IGL. EGL: external granular cell layer; 
MCL: molecular cell layer; PCL: Purkinje cell layer; IGL: inter-
nal granular cell layer; WM: white matter. Bars are 40 µmBMC Neuroscience 2006, 7:6 http://www.biomedcentral.com/1471-2202/7/6
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whereas the cytoplasm of these cells is free of immunore-
activity (compare to calbindin in Fig. 3). As pointed out
already, some cells in the IGL are strongly positive for
HRP-3 and may represent Golgi cells (Fig. 3I arrows).
Immunohistochemical analysis of glial expression in brains 
of adult mice
Figures 3C and 3F (arrows) show that HDGF and HRP-2
are also expressed in nuclei of cells within white matter
tracts of the cerebellum (arrows in Fig. 3C+F). In contrast,
no HRP-3 positive cells were detected in the cerebellar
white matter (Fig. 3I). The occurrence of HDGF and HRP-
2 positive cells in white matter tracts led us to investigate
the expression of HDGF family members in glial cells. For
this purpose we applied the specific antisera directed
against the three proteins together with a monoclonal
antibody recognizing glial fibrillary acidic protein (GFAP,
Fig. 4). Figure 4 shows that cells with HDGF and HRP-2
positive nuclei also express GFAP (Fig. 4C+F arrowheads).
In contrast, HRP-3 did not localize to GFAP positive cells
(Fig. 4I). Therefore, astrocytes express HDGF and HRP-2
but no HRP-3.
To investigate the expression of HDGF, HRP-2 and HRP-3
in oligodendrocytes we performed coimmunostainings
on brain stem sections for these three proteins together
with an antibody against 2,3-cyclonucleotid-phosphodi-
esterase (CNPase, Fig. 5). Again, HDGF and HRP-2 were
strongly expressed by cells positive for CNPase (arrow-
heads in Fig. 5C+F) whereas these cells showed only very
limited HRP-3 expression (Fig. 5I, arrowheads) when
compared to cells most likely representing neuronal cells
of the brain stem that are strongly positive for HRP-3 (Fig.
5I, asterisk).
Examination of HDGF, HRP-2 and HRP-3 coexpreesion
Immunohistochemistry with the different cellular mark-
ers but also prima vista comparison of HDGF and HRP-2
expression in the cerebellum (e.g. Fig. 2A and 2D, Fig. 3A
and 3D) revealed a considerable overlap in expression
pattern for HDGF and HRP-2 in neuronal as well as glial
cells. In contrast, coexpression with HRP-3 seemed to be
restricted to special types of neuronal cells (for example
Expression of HDGF family members in astrocytes Figure 4
Expression of HDGF family members in astrocytes. 
Antibodies against HDGF (A), HRP-2 (D), HRP-3 (G) and 
GFAP (B, E, H) were used to detect the respective proteins 
in brain slices of adult mice. In all cases a part of the hippoc-
ampal region is shown. Double immunfluorescence demon-
strates that HDGF (C, arrows) and HRP-2 (F, arrows) are 
expressed in cells positive for GFAP. In contrast no costain-
ing of cells containing both GFAP as well as HRP-3 could be 
detected (I). Bars are 40 µm.
Expression of HDGF family members in oligodendrocytes Figure 5
Expression of HDGF family members in oligodendro-
cytes. Antibodies against HDGF (A), HRP-2 (D), HRP-3 (G) 
and CNPase (B, E, H) were used to detect the respective 
proteins in brain slices of adult mice. In all cases fiber tracts 
in the brain stem are shown. Double immunfluorescence 
demonstrates that HDGF (C, arrowheads) and HRP-2 (F, 
arrowheads) are strongly expressed by cells also positive for 
CNPase. In contrast HRP-3 is only very weakly expressed by 
this cell type (I, arrowheads) when compared to other HRP-
3 positive cells which most likely represent brain stem neu-
rons (I, asterisks). Bars are 25 µm.BMC Neuroscience 2006, 7:6 http://www.biomedcentral.com/1471-2202/7/6
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Purkinje cells). To investigate the degree of coexpression
of HDGF and HRP-3 in more detail we raised an antise-
rum against HDGF in sheep to perform double
immunfluorescence of both proteins. In addition to cere-
bellar sections we also investigated hippocampal and cor-
tical sections (Fig. 6 + 7).
These pictures reveal that HDGF expression is widespread
in all brain areas investigated. The same applies for HRP-
3, except for the cerebellum, in which the number of HRP-
3 expressing cells is limited. There is considerable colocal-
ization of HDGF and HRP-3 in the hippocampus but
whereas HDGF is equally distributed over the whole hip-
pocampus there is lower HRP-3 expression in the dentate
gyrus than in the other parts of this brain region (Fig.
6A+B). In a higher magnification of this brain region cells
can be distinguished that predominantly express HRP-3
(Fig. 6D, arrowheads) as well as a cell layer at the inner
part of the dentate gyrus showing a particularly high
expression of HDGF and being negative for HRP-3 (Fig.
6D, arrows). In addition, ependymal cells of the ventricu-
lar surface (Fig. 6C, arrow) where also found to be only
positive for HDGF.
In the cortex cells expressing HDGF and HRP-3 in layer I
are less frequent than in layer II, however, there are only
very few cells in layer I which express HDGF only (Fig. 7C,
arrows). In good correlation to the ependymal cells men-
tioned above meningeal fibroblasts forming the pia mater
are only expressing HDGF (Fig. 7C, PM).
In contrast to the hippocampus and cortex coexpression
of HDGF and HRP-3 is limited in the cerebellum. As
Comparison of HDGF and HRP-3 expression Figure 6
Comparison of HDGF and HRP-3 expression. Anti-
bodies against HDGF (A) or HRP-3 (B) were used to detect 
both proteins in the hippocampus of an adult mouse. Com-
parison of the double immunfluorescence demonstrates the 
lack of expression of HRP-3 in cells covering the ventricel 
wall of the hippocampal region (C, arrow), whereas HDGF is 
clearly expressed in this cell type. In contrast, hippocampal 
neurons coexpress both family members, but whereas 
HDGF is found to a similar extent in all neurons of the hip-
pocampal formation (A), neurons of the dentate gyrus show 
only weak expression of HRP-3 when compared to the rest 
of the hippocampus (B). Higher magnification of this region 
demonstrates the existence of cells predominantly express-
ing HRP-3 (D, arrowheads) as well as a cell layer only posi-
tive for HDGF (D, arrows). CA: cornu ammonis; Sub: 
subiculum; DG: dentate gyrus; Bar in C is 80 µm; bar in D is 
40 µm.
HDGF and HRP-3 expression in the dentate gyrus Figure 7
HDGF and HRP-3 expression in the dentate gyrus. 
Antibodies against HDGF (A, D) or HRP-3 (B, E) were used 
to detect both proteins in the neocortex and cerebellum of 
an adult mouse. Comparison of the double immunfluores-
cence demonstrates the lack of expression of HRP-3 in cells 
building the pia mater at the surface of the cortex (PM in C) 
and some cells in layer I (C, arrows), whereas cells in the rest 
of the cortex show a high degree of coexpression of HDGF 
and HRP-3. A lower degree of coexpression is found in the 
cerebellum, where HRP-3 family member is only expressed 
in Purkinje cells and Golgi cells of the IGL. Some of these 
HRP-3 positive cells do not (E+F, asterisks) and some do also 
express HDGF (D-F, arrowheads). PM: Pia Mater; I+II: layer I 
and II; EGL: external granular cell layer; MCL: molecular cell 
layer; PCL: purkinje cell layer; IGL: internal granular cell 
layer; WM: white matter. Bars are 40 µm.BMC Neuroscience 2006, 7:6 http://www.biomedcentral.com/1471-2202/7/6
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already shown in figure 2, in the cerebellum strongest
expression of HRP-3 was found in cells most likely repre-
senting inhibitory interneurons of the internal granular
cell layer (Golgi cells, Fig. 7D-F + 2I arrowheads). Very few
unidentified cells in the IGL are only positive for HRP-3
(asterisks in Fig. 7E+F).
In the double stainings between HDGF and HRP-3 differ-
ences in the pattern of expression were most striking in
the cerebellum (Fig. 7D-F). Therefore, to get an idea about
the percentages of cells in this brain region positive for the
two proteins we performed double staining with propid-
ium iodide to label the nuclei of all cells. Figure 8 shows
examples for these stainings for HDGF (Fig. 8A-C) and
HRP-3 (Fig. 8D-F). For each marker three independent
pictures were taken and used to count all cells (propidium
iodide) and cells positive for HDGF or HRP-3, respec-
tively. Cells were independently counted for the molecu-
lar layer (MCL) on the one hand and the Purkinje cell
layer (PCL) together with the internal granule cell layer
(IGL) on the other hand. As can be seen already in figure
8A–C 100% of the cells in the cerebellum express HDGF.
For HRP-3 we obtained different results for the two
counted regions. In the MCL in the three pictures exam-
ined 64, 68 and 69% of all cells showed HRP-3 immunre-
activity. Because of the restriction of HRP-3 to neuronal
cells this cells most likely represent basket/stellate cells
another type of inhibitory interneuron in the cerebellum.
In the PCL and IGL together because of the high amount
of granule cells negative for this family member less than
5% of cells were positive for HRP-3. As mentioned before
Purkinje cells are positive for HRP-3 (Fig. 8D arrows). As
can be seen in figure 8E there are additional cells in the
Purkinje cell layer that do not stain for HRP-3 most likely
representing the cell bodies of radial glia cells that lie in
direct contact with the Purkinje cell bodies in this cell
layer (Fig. 8E asterisks). In addition there is not a sharp
boundary between this layer and the granule cell layer.
Therefore some of this HRP-3 negative cells display also
granule cells.
Examination of the frequency of HDGF and HRP-3 express- ing cells in the cerebellum Figure 8
Examination of the frequency of HDGF and HRP-3 
expressing cells in the cerebellum. Antibodies against 
HDGF (A, C) or HRP-3 (D, F) were used to detect both pro-
teins in the cerebellum of an adult mouse. To label the nuclei 
of all cells in the sections counterstaining with propidium 
iodide was performed (B,C and E,F). Double stained sections 
were used to calculate the percentage of cells positive for 
HDGF or HRP-3, respectively. Whereas HDGF is expressed 
in all cells, HRP-3 expression is much more restricted (for 
details see text). Cells labeled with arrows in D represent 
HRP-3 positive Purkinje cells. Asterisks in E mark most likely 
radial glia cells. MCL: molecular cell layer; PCL: purkinje cell 
layer; IGL: internal granular cell layer; Bars are 25 µm. Expression of HDGF family members in neural cell culture Figure 9
Expression of HDGF family members in neural cell 
culture. Proteins extracted from cultured neurons, astro-
cytes, microglia, and oligodendrocytes were subjected to 
SDS-PAGE as described under material and methods. After 
blot transfer membrane was incubated with antibodies 
against the different HDGF family members or GAP-43 and 
actin as controls. Whereas HDGF is expressed to a similar 
extent in all four cell types, HRP-2 and HRP-3 show a more 
restricted expression pattern in neural cell cultures. Molecu-
lar weights of marker proteins in kiloDalton are given on the 
left.BMC Neuroscience 2006, 7:6 http://www.biomedcentral.com/1471-2202/7/6
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Expression of HDGF, HRP-2 and HRP-3 in cultured cells
To compare the results obtained by immunhistochemistry
of brain sections of adult mice with cell cultures of neuro-
nal and glial cells, we prepared cultures of neurons, astro-
cytes, microglia and oligodendrocytes as described in
material and methods. HDGF, HRP-2 and HRP-3 were
quantified in cell homogenates by Western blot analysis.
For HDGF and HRP-3 the results of these Western blots
confirmed the data of immunhistochemistry. Whereas
HDGF showed strong expression in all of the four cell
types, high amounts of HRP-3 were only found in cul-
tured neurons (Fig. 9). Only low amounts of HRP-3 were
detected in glial cell cultures. To exclude that this observa-
tion might be due to residual neuronal cells in the glial
cell culture we analyzed the samples for the presence of
the neuron specific marker protein growth-associated pro-
tein-43 (GAP-43). This protein was only detected in cul-
tured neurons, but not in the glial cell cultures. In contrast
to the data obtained on adult mouse brain sections, HRP-
2 is not or only weakly expressed in cultured astrocytes or
neuronal cells, respectively. Strong HRP-2 expression was
found in cultured oligodendrocytes and microglia.
Discussion
The family of Hepatoma derived growth factor related
proteins comprises six members. Whereas HDGF and
HRP-2 are expressed in a wide variety of tissues including
the nervous system, HRP-3 is expressed in the nervous sys-
tem only. Previous data indicate that at least HDGF and
HRP-3 proteins are expressed by differentiated neurons
[27]. Western blots of protein extracts of different brain
regions demonstrate a rather ubiquitous expression of
HDGF family members in various CNS regions. HDGF is
the most evenly distributed member whereas HRP-2 and
HRP-3 expression varies between different regions (Fig.
1). On the cellular level HRP-3 shows the most restricted
expression when compared to HDGF and HRP-3. HRP-3
was strongly expressed in neurons only. Expression in
neurons is, however, not ubiquitous but occurs only in a
subpopulation: e.g. Purkinje cells in the cerebellum and
neurons within the subiculum and cornu ammonis of the
hippocampus are strongly positive whereas cerebellar
granule cells are negative for HRP-3. The term granular
cell is used to describe major cell populations in the cere-
bellar cortex the olfactory bulb and the dentate gyrus.
These cells share the characteristics of being born late dur-
ing development and they all express at least one com-
mon molecular marker, termed RU49, that has been
implicated in their specification [30]. This has led to the
suggestion that these diverse kinds of granule cells are of
a common developmental origin [30]. This is supported
by the observation that granule cells of the dentate gyrus
show a remarkably reduced expression of HRP-3 in addi-
tion to its missing expression in cerebellar granule cells
described above.
Beside the correlation between HRP-3 and neuronal ori-
gin, the limited cerebellar expression of this protein
regarding neuron subtypes correlates also with the trans-
mitter phenotype of this cells. Whereas granule cells are
glutamatergic all other neurons of this brain structure use
gamma amino butyric acid (GABA) as a neurotransmitter.
Ptf1a, which was reported to be a lineage determinator in
the cerebellum, for example, is also exclusively expressed
by GABAergic neurons of the cerebellum [31,32]. At least
for the cerebellum HRP-3 might therefore be a marker to
distinguish between excitatory and inhibitory neuronal
subpopulations.
Except for neurons very low amounts of HRP-3 could also
be detected in oligodendrocytes located in the brain stem.
In contrast, white matter tracts of the cerebellum con-
tained no HRP-3 expressing cells. Studies on the place and
time of origin of oligodendrocytes have demonstrated
heterogeneity inside of this cell population [33]. Maybe
HRP-3 expression in oligodendrocytes similar to our
observations for granule neurons is also dependent on
their time of birth. In contrast to oligodendrocytes HRP-3
could not be detected in astrocytes in vivo.
Expression of HDGF and HRP-2 is much less restricted
than that of HRP-3. Both proteins are found in neurons,
astrocytes and oligodendroglia, in meningeal fibroblasts
and ependymal cells. Immunohistochemistry shows that
HDGF and HRP- 2 expression in neurons is widespread,
except for the cerebellum this also applies for HRP-3. Our
data indicate that all three proteins are found in the
majority of neurons. However, our data do not allow to
exclude that a minor subpopulation of neurons may in
fact be negative for HDGF and HRP-2.
The results obtained by immunohistochemistry of brain
slices are only partly reflected in cultured cells.
As expected, in cultured cells HRP-3 is predominantly
expressed in neurons and only to a low extent in glial cells.
Expression levels of HDGF are similar in all cells investi-
gated, which also reflects the in vivo situation. Clear dif-
ferences between cell culture and tissue data regarding the
expressing cell type were detected in the case of HRP-2.
Whereas in immunhistochemistry cells positive for GFAP
showed also HRP-2 immunreactivity, no HRP-2 protein
could be detected in the astrocytic culture. This may either
reflect species differences since the cultures were prepared
from rat brain or developmental differences, because
immunohistochemistry was performed on brain sections
of adult animals, whereas cultures were prepared from
neonatal rats.
It has already been noted previously that the antisera
against the various HRP proteins detect more than oneBMC Neuroscience 2006, 7:6 http://www.biomedcentral.com/1471-2202/7/6
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polypeptide in Western blot analysis. The HDGF antise-
rum recognizes a predominant 38 kDa and a minor 40
kDa polypeptide, respectively. The molecular basis for this
is unclear. Similarly, the HRP-2 antiserum detects three
polypeptides of 90, 110 and 125 kDa in Western blots.
Thus, as already shown for HDGF and HRP-3 [27] also
HRP-2 is migrating at a molecular weight significantly
higher than the one predicted (74 kDa) by its primary
amino acid sequence. Whether this is due to posttransla-
tional modifications or as shown for HDGF and HRP-3 to
abnormal migration behavior in SDS-PAGE has to be
determined. In contrast, in most tissues only a single HRP-
3 polypeptide can be detected. Only in homogenates of
piriform cortex and the amygdala complex a faint 35 kDa
polypeptide is detectable. Similarly, low amounts of addi-
tional 35 kDa and 33 kDa polypeptides cross react in
homogenates of cultured neurons and astrocytes respec-
tively. Thus, all of the antisera detect several polypeptides.
The functional significance of these different polypeptides
is unknown.
The overlapping expression pattern of HDGF and HRP-2
and for neuronal cells also HRP-3 suggests different func-
tions for these proteins. Beside its proliferating activity
HDGF displays also survival activity for neurons [34]. A
relation of this factor to cell death and survival is further
underlined by the observation that it is involved in TNFα
induced apoptosis in Hela cells [35]. It can be speculated
that the function of HDGF in neurons during develop-
ment changes from more proliferative aspects to cellular
survival. Expression in glial cells indicates that within the
nervous system HDGF may have similar functions also in
non-neuronal cells. For HRP-2 much less is known regard-
ing the function of this family member. Structurally it
shows the highest similarities to LEDGF and also func-
tionally their might be an overlap between these two pro-
teins. For example, for both of them it was shown that
they bind to and enhance the activity of HIV integrase
[18]. Similar to HDGF, LEDGF was reported to be neuro-
protective [36]. Whether this is also true for HRP-2 has to
be determined.
HRP-3 in contrast to the other two family members seems
to be restricted to neurons, but the nature of its function
in these cells is still obscure. Beside its localisation in the
cell nucleus at least in younger animals a prominent pro-
tein signal in neurites can be observed [27]. Whether
HRP-3 therefore is involved in the extension or mainte-
nance of these cellular processes has to be addressed in the
future.
Conclusion
Prior studies have demonstrated HDGF as well as HRP-3
expression in the central nervous system [12,34]. The pre-
sented data show a wide distribution of both family mem-
bers as well as HRP-2 in brain neurons. In contrast glial
cells express only low amount or even no HRP-3 but
HDGF as well as HRP-2. This observation point to a spe-
cial function of HRP-3 for neuronal cells. In addition, the
overlapping expression pattern of HDGF and HRP-2 and
for neuronal cells also HRP-3 suggests different functions




For Western blot analysis antibodies against β-actin (pan
Ab-5) was obtained from Dianova (Hamburg, Germany)
and against GAP-43 from Chemicon International (Hof-
heim, Germany). For immunhistochemistry antibodies
against NeuN, Calbindin and GFAP were from Chemicon
International, Vector Laboratories (Burlingham, CA, USA)
and Sigma (Munich, Germany) respectively.
Rabbit antibodies against HDGF, HRP-2 and HRP-3 were
produced and purified as described elsewhere [1]. The
sheep antiserum against HDGF was raised against the his-
tidine tagged protein as described for the rabbit antibod-
ies [1,27]. Three aliquots of about 500 µg protein each
were used to immunize a sheep (Diagnostics Scotland,
Edinburgh, Scotland). Immunization was performed
according to local governmental regulations. In order to
obtain specific antibodies suitable for immunhistochem-
istry rabbit and sheep sera were purified by affinity chro-
matography using GST (glutathione S-transferase) fusion
proteins of the different growth factors. Therefore, mouse
HDGF, HRP-2 and HRP-3 coding regions were cloned
into the pGEX4T3 vector (Amersham Pharmacia Biotech,
Freiburg, Germany) using BamHI and SalI restriction
sites. After purification via glutathione sepharose (Amer-
sham Pharmacia Biotech, Freiburg, Germany) the purified
proteins were coupled to Affigel 10 using the protocol
supplied by the manufacturer (Bio-Rad, München, Ger-
many). The resulting matrices were used for immunoaf-
finity purification of antibodies specific for the respective
growth factor. All antibodies were examined for crossreac-
tivity by preincubation with the respective recombinant
protein (for results see file 1 and 2 of the additional mate-
rial and Abouzied and coworkers [27]).
All fluorescently labeled secondary antibodies used for
immunhistochemistry were obtained from Dianova
(Hamburg, Germany).
Preparation of protein extracts and western blot analysis
Protein extracts from the different brain regions of adult
rat brain were prepared by homogenization in TBS (Tris-
buffered saline; 20 mM Tris/HCl, pH 7.0, 150 mM NaCl)
containing 1% Nonidet P40 and protease inhibitors (5
mM EDTA, 2 mM phenylmethyl sulfonylfluoride, 1 µg/mlBMC Neuroscience 2006, 7:6 http://www.biomedcentral.com/1471-2202/7/6
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leupeptin and 1 µg/ml pepstatin). After homogenization,
samples were centrifuged at 20.000 g for 20 min at 4°C to
remove unhomogenized material. The protein content in
the supernatant was determined by a detergent-compati-
ble assay (BCA™ protein assay; Pierce). Equal amounts of
protein for each brain region were loaded on to a SDS/
PAGE gel (10% acrylamide) and resolved according to the
method of Laemmli [37].
To obtain protein samples for Western blotting, neural
cell cultures (on 50 mm dishes) were washed with 5 ml
ice-cold phosphate buffered saline (PBS, 10 mM potas-
sium phosphate buffer pH 7.4, containing 150 mM NaCl)
and lysed for 10 minutes in 400 µl lysis solution (0.3 µM
aprotinin, 1 µM leupeptin, 1 µM pepstatin, 100 µM phe-
nylmethyl sulfonylfluoride in H2O) on ice. Aliquots of the
lysates were lyophilised and used for protein assays and
for Western blot analysis.
After electrophoresis, proteins were transferred to a PVDF
membrane (Immobilon-P™; Millipore, Schwalbach, Ger-
many). Free binding sites on the membrane were blocked
by incubation in 3% (w/v) skimmed milk in TBST (TBS
containing 0.05% Tween 20). Primary antibodies against
HRP-3 (1:1.000), HRP-2 (1:500), HDGF (1:1.000), actin
(1:10.000) and GAP 43 (1:1.000) and peroxidase-labelled
secondary antibodies against rabbit and sheep (both
1:20.000; Dianova) were incubated in TBST containing
3% skimmed milk for 2 h at room temperature. After three
washings in TBST, bound antibodies were visualized by
ECL®  system (Amersham Pharmacia Biotech). For the
detection of the different target proteins on the same
PVDF membrane remaining antibodies were stripped by
incubation with Glycine/HCl pH 3.0 for 20 min at room
temperature. For the Western blot of the brain region
homogenates detection was performed in the order HRP-
2/HDGF/HRP-3/actin, for the Western blot of the neural
cell culture samples in the order HRP-2/HDGF/HRP-3/
actin/GAP 43, respectively.
Cell cultures of neural cells
Neuron-rich primary cultures were prepared from the
brains of embryonal (E16) Wistar rats as previously
described [38]. Experiments were conducted at an age of 6
days. These cultures contain approximately 5% astroglial
cells [39] but no oligodendroglial or ependymal cells
[38]. Astroglia-rich primary cultures derived from the
brains of neonatal Wistar rats were prepared and main-
tained as described [40]. The results were obtained with
14- to 21-day-old cultures. These cultures contain minor
numbers of oligodendroglial, ependymal and microglial
cells [41]. Microglia-rich secondary cultures were pre-
pared from astroglia-rich primary cultures as described
previously [42]. The cultures were used at an age of 6 days.
These cultures contain about 90% microglial cells and
small quantities of astroglial and oligodendroglial cells
[42]. Oligodendroglia-rich secondary cultures derived
from astroglia-rich primary cultures in 175 cm2 flasks
were prepared as recently described [43]. The cultures
were used at an age of 6 days. The cultures contain about
90% oligodendroglial cells and the majority of the
remaining cells are astroglial cells [43].
Immunhistochemistry
Immunhistochemistry was performed as described
before. Briefly, mice were deeply anesthetized by intra-
peritoneal injection of 2.5% avertin in 0.9% saline (0.8
ml/100 g body weight). Subsequently, they were transcar-
dially perfused with 0.4 ml/g body weight of Ringers solu-
tion for mammalians, followed by 2 ml/g body weight of
4% (w/v) freshly prepared paraformaldehyde in PBS. Fol-
lowing perfusion, brains were removed from the skull and
postfixed for 7 h at room temperature in the same fixative
and afterwards kept in PBS over night. Then, 40 µm thick,
sagittal sections were cut in PBS using a Leica vibratome
(VT1000S, Leica, Wetzlar, Germany). To visualize the dif-
ferent antigens, sections were washed in PBS for 10 min
and permeabilized by incubation in 0.5% Triton X-100/
PBS for 30 min. Non-specific protein binding sites were
blocked using 2% bovine serum albumin in PBS for 1 h
followed by incubation of the primary antibodies in
blocking solution overnight at 4°C in a humidified cham-
ber. Unbound antibodies were removed by washing in
PBS and sections were incubated with the respective fluo-
rescently labelled antibodies diluted in blocking solution
for 2 h at RT. After 2 washes in PBS and one wash in dis-
tilled water immunfluorescence was analyzed by laser
scan microscopy using a Leica TCS SP2 instrument.
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